Alzheon, Inc. announced that David Nikodem, Ph.D., has joined its board of directors. Dr. Nikodem is a senior representative of the global healthcare-focused investment firm Ally Bridge Group. Most recently, from 2010 to 2013, Dr. Nikodem served as a Portfolio Manager at Exane Asset Management in Paris, where he managed Exane Equinox, a global healthcare investment fund.
1st Jan change | Capi. | |
---|---|---|
+43.36% | 54.63B | |
-5.31% | 39.92B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B | |
-11.83% | 10.74B |